首页 > 市场调查报告书 > 製药

再生医学细胞疗法

市场调查报告书

商品编码

1532414

干细胞製造市场：按类型、按应用、按最终用户、按地区

Stem Cell Manufacturing Market, By Type, By Application, By End-User, By Geography

出版日期: 2024年07月24日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年，全球干细胞製造市场将达到128亿美元，预计2024年至2031年复合年增长率为13%，到2031年将达到302亿美元。

报告范围		报告详情
基准年	2023年	2024年市场规模	128亿美元
实际资料	2019-2023	预测期	2024-2031
预测 2024-2031 年复合年增长率：	13.00%	2031年价值预测	302亿美元

图：2024 年各地区干细胞製造市场占有率（%）

近年来，由于慢性疾病的盛行率不断上升以及基于干细胞的治疗方法的快速发展，全球干细胞製造市场经历了显着增长。干细胞具有治疗多种退化性疾病和再生受损组织的潜力。此外，製药公司加大对干细胞治疗和产品开发研发活动的投资也促进了市场成长。然而，与干细胞治疗相关的高成本以及与干细胞采购相关的伦理问题可能会阻碍市场扩张。

市场动态：

推动全球干细胞製造市场成长的关键因素包括全球慢性疾病的流行、基于干细胞的成功治疗方法数量的增加以及公共和私营部门对干细胞研究的资金的增加。然而，与干细胞治疗相关的高成本以及与干细胞采购相关的伦理问题可能会限制市场成长。此外，干细胞在药物发现和市场开拓中的广泛应用预计将在预测期内为市场相关人员提供利润丰厚的商机。干细胞疗法越来越多地用于癌症以及各种血液和免疫疾病。根据世界卫生组织的资料，癌症是全球头号死亡原因，预计光是 2020 年就有约 1,000 万人死亡。由于乳腺癌、肺癌、结肠癌、直肠癌和前列腺癌是最常见的，市场开拓正在专注于开髮用于癌症治疗的新干细胞治疗方法。

本研究的主要特点

本报告详细分析了全球干细胞製造市场，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
该报告根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，提供了全球干细胞製造市场主要企业的概况。
该报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球干细胞製造市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

公司简介
- Sartorius
- Becton, Dickinson and Company
- Fujifilm Holdings Corporation（Cellular Dynamics）
- Lonza Group
- Stemcell Technologies
- Corning Incorporated
- Merck Group
- Thermo Fisher Scientific
- Pluristem Therapeutics Inc.
- Miltenyi Biotec
- Takeda Pharmaceutical Company Limited
- DAIICHI SANKYO COMPANY, LIMITED
- AbbVie Inc.
- Bristol-Myers Squibb Company
- GlaxoSmithKline Plc
- Danaher Corporation
- Accegen
- Cellular Engineering Technologies

第10章分析师建议

命运之轮
分析师观点
一致的机会图

第十一章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI5381

Global Stem Cell Manufacturing market is estimated to be valued at USD 12.8 Bn in 2024 and is expected to reach USD 30.2 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 12.8 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	13.00%	2031 Value Projection:	US$ 30.2 Bn

Figure. Stem Cell Manufacturing Market Share (%), By Region 2024

The global stem cell manufacturing market has been witnessing significant growth in the recent past due to the increasing incidence of chronic diseases and rapid advancement in stem cell-based therapies. Stem cells have the potential to treat various degenerative diseases and regeneration of damaged tissues. Moreover, the rising investments by pharmaceutical companies in R&D activities focused on developing stem cell therapies and products is fueling market growth. However, high costs associated with stem cell therapies and ethical issues related to stem cell procurement may hinder the market expansion.

Market Dynamics:

The key drivers spurring the growth of global stem cell manufacturing market include growing prevalence of chronic diseases globally, increasing success of stem cell-based therapies, rising funding from public and private players for stem cell research. However, high costs associated with stem cell therapies and ethical issues related to stem cell procurement may restrain the market growth. Moreover, expanded applications of stem cells in drug discovery and development is expected to present lucrative opportunities for market players over the forecast period. for instance according to WHO In February 2022, increasing awareness of the therapeutic potential of stem cells is fueling market expansion. Stem cell treatments are increasingly used for cancer and various blood and immune disorders. WHO data indicates cancer as a leading cause of death globally, with nearly 10 million deaths in 2020 alone. With breast, lung, colon, rectum, and prostate cancers being the most common, market players are focusing on developing new stem cell therapies for cancer treatment.

Key Features of the Study:

This report provides in-depth analysis of the global stem cell manufacturing market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global stem cell manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Thermo Fisher Scientific, Merck Group, Becton, Dickinson and Company, Lonza Group, Miltenyi Biotec, Takara Bio, STEMCELL Technologies, and PromoCell GmbH.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global stem cell manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation-

By Type
- Product
- Services
By Application
- Stem Cell Therapy
- Drug Discovery and Development
- Stem Cell Banking
By End-User
- Biopharmaceutical companies and CRO
- Cell Banks and Tissue Banks
- Academic & Research Institutes
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Sartorius
- Becton, Dickinson and Company
- Fujifilm Holdings Corporation (Cellular Dynamics)
- Lonza Group
- Stemcell Technologies
- Corning Incorporated
- Merck Group
- Thermo Fisher Scientific
- Pluristem Therapeutics Inc.
- Miltenyi Biotec
- Takeda Pharmaceutical Company Limited
- DAIICHI SANKYO COMPANY, LIMITED
- AbbVie Inc.
- Bristol-Myers Squibb Company (US)
- GlaxoSmithKline Plc
- Danaher Corporation
- Accegen
- Cellular Engineering Technologies

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Stem Cell Manufacturing Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Stem Cell Manufacturing Market, By Product Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Product
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Stem Cell Manufacturing Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Stem Cell Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Drug Discovery and Development
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Stem Cell Banking
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Stem Cell Manufacturing Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Biopharmaceutical companies and CRO
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cell Banks and Tissue Banks
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Stem Cell Manufacturing Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Sartorius
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Becton, Dickinson and Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Fujifilm Holdings Corporation (Cellular Dynamics)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Lonza Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Stemcell Technologies
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Corning Incorporated
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Thermo Fisher Scientific
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pluristem Therapeutics Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Miltenyi Biotec
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Takeda Pharmaceutical Company Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- DAIICHI SANKYO COMPANY, LIMITED
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bristol-Myers Squibb Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GlaxoSmithKline Plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Danaher Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Accegen
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cellular Engineering Technologies

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

干细胞製造市场：按类型、按应用、按最终用户、按地区